Pharma & Biotech ×
Mar 2020
has divested its Alprostadil products to
Feb 2020
has acquired
Jun 2019
has acquired
Dec 2018
Hospira, a Pfizer company, has divested its UK compounding business to
Jun 2018
has divested its Holmes Chapel manufacturing site to
Feb 2018
has divested the global rights to LEUKINE® and associated manufacturing assets to
Jul 2016
has divested nitrate product Russian and Ukranian rights to
a Pamplona Capital Management-backed company
Jun 2016
has divested its Tucson research facility and operations to
Feb 2016
has divested nitrate product rights in selected markets to
Mar 2015
has entered a major multi-component strategic alliance with